ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Coagulants Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27Q6797
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Blood Coagulants Market Insights and Forecast to 2028
BUY CHAPTERS

Global Blood Coagulants Market Research Report 2025

Code: QYRE-Auto-27Q6797
Report
September 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Bayer
Novo Nordisk
Takeda
SOBI
Octapharma AG
CSL Limited

Blood Coagulants Market Size

The global market for Blood Coagulants was valued at US$ 456 million in the year 2024 and is projected to reach a revised size of US$ 704 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Blood Coagulants Market

Blood Coagulants Market

Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood Coagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Coagulants.
The Blood Coagulants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Coagulants market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Coagulants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.

Scope of Blood Coagulants Market Report

Report Metric Details
Report Name Blood Coagulants Market
Accounted market size in year US$ 456 million
Forecasted market size in 2031 US$ 704 million
CAGR 6.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Sale Channel
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Bayer, Novo Nordisk, Takeda, SOBI, Octapharma, CSL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Blood Coagulants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Blood Coagulants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Blood Coagulants Market growing?

Ans: The Blood Coagulants Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Blood Coagulants Market size in 2031?

Ans: The Blood Coagulants Market size in 2031 will be US$ 704 million.

Who are the main players in the Blood Coagulants Market report?

Ans: The main players in the Blood Coagulants Market are Pfizer, Bayer, Novo Nordisk, Takeda, SOBI, Octapharma, CSL

What are the Type segmentation covered in the Blood Coagulants Market report?

Ans: The Types covered in the Blood Coagulants Market report are Recombinant Coagulation Factor, Plasma Coagulation Factor

Recommended Reports

Blood Coagulation Devices

Blood Transfusion Markets

Hemostats & Coagulation

1 Blood Coagulants Market Overview
1.1 Product Definition
1.2 Blood Coagulants by Type
1.2.1 Global Blood Coagulants Market Value Comparison by Type (2024 VS 2031)
1.2.2 Recombinant Coagulation Factor
1.2.3 Plasma Coagulation Factor
1.3 Blood Coagulants by Sale Channel
1.3.1 Global Blood Coagulants Market Value by Sale Channel (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Blood Coagulants Market Size Estimates and Forecasts
1.4.1 Global Blood Coagulants Revenue 2020-2031
1.4.2 Global Blood Coagulants Sales 2020-2031
1.4.3 Global Blood Coagulants Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Blood Coagulants Market Competition by Manufacturers
2.1 Global Blood Coagulants Sales Market Share by Manufacturers (2020-2025)
2.2 Global Blood Coagulants Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Blood Coagulants Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Blood Coagulants, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Blood Coagulants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Coagulants, Product Type & Application
2.7 Global Key Manufacturers of Blood Coagulants, Date of Enter into This Industry
2.8 Global Blood Coagulants Market Competitive Situation and Trends
2.8.1 Global Blood Coagulants Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Blood Coagulants Players Market Share by Revenue
2.8.3 Global Blood Coagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood Coagulants Market Scenario by Region
3.1 Global Blood Coagulants Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Blood Coagulants Sales by Region: 2020-2031
3.2.1 Global Blood Coagulants Sales by Region: 2020-2025
3.2.2 Global Blood Coagulants Sales by Region: 2026-2031
3.3 Global Blood Coagulants Revenue by Region: 2020-2031
3.3.1 Global Blood Coagulants Revenue by Region: 2020-2025
3.3.2 Global Blood Coagulants Revenue by Region: 2026-2031
3.4 North America Blood Coagulants Market Facts & Figures by Country
3.4.1 North America Blood Coagulants Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Blood Coagulants Sales by Country (2020-2031)
3.4.3 North America Blood Coagulants Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Blood Coagulants Market Facts & Figures by Country
3.5.1 Europe Blood Coagulants Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Blood Coagulants Sales by Country (2020-2031)
3.5.3 Europe Blood Coagulants Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Coagulants Market Facts & Figures by Region
3.6.1 Asia Pacific Blood Coagulants Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Blood Coagulants Sales by Region (2020-2031)
3.6.3 Asia Pacific Blood Coagulants Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Blood Coagulants Market Facts & Figures by Country
3.7.1 Latin America Blood Coagulants Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Blood Coagulants Sales by Country (2020-2031)
3.7.3 Latin America Blood Coagulants Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Coagulants Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Coagulants Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Blood Coagulants Sales by Country (2020-2031)
3.8.3 Middle East and Africa Blood Coagulants Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Blood Coagulants Sales by Type (2020-2031)
4.1.1 Global Blood Coagulants Sales by Type (2020-2025)
4.1.2 Global Blood Coagulants Sales by Type (2026-2031)
4.1.3 Global Blood Coagulants Sales Market Share by Type (2020-2031)
4.2 Global Blood Coagulants Revenue by Type (2020-2031)
4.2.1 Global Blood Coagulants Revenue by Type (2020-2025)
4.2.2 Global Blood Coagulants Revenue by Type (2026-2031)
4.2.3 Global Blood Coagulants Revenue Market Share by Type (2020-2031)
4.3 Global Blood Coagulants Price by Type (2020-2031)
5 Segment by Sale Channel
5.1 Global Blood Coagulants Sales by Sale Channel (2020-2031)
5.1.1 Global Blood Coagulants Sales by Sale Channel (2020-2025)
5.1.2 Global Blood Coagulants Sales by Sale Channel (2026-2031)
5.1.3 Global Blood Coagulants Sales Market Share by Sale Channel (2020-2031)
5.2 Global Blood Coagulants Revenue by Sale Channel (2020-2031)
5.2.1 Global Blood Coagulants Revenue by Sale Channel (2020-2025)
5.2.2 Global Blood Coagulants Revenue by Sale Channel (2026-2031)
5.2.3 Global Blood Coagulants Revenue Market Share by Sale Channel (2020-2031)
5.3 Global Blood Coagulants Price by Sale Channel (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Blood Coagulants Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Blood Coagulants Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Blood Coagulants Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Blood Coagulants Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Company Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Blood Coagulants Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novo Nordisk Blood Coagulants Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Company Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Blood Coagulants Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Blood Coagulants Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 SOBI
6.5.1 SOBI Company Information
6.5.2 SOBI Description and Business Overview
6.5.3 SOBI Blood Coagulants Sales, Revenue and Gross Margin (2020-2025)
6.5.4 SOBI Blood Coagulants Product Portfolio
6.5.5 SOBI Recent Developments/Updates
6.6 Octapharma
6.6.1 Octapharma Company Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Blood Coagulants Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Octapharma Blood Coagulants Product Portfolio
6.6.5 Octapharma Recent Developments/Updates
6.7 CSL
6.7.1 CSL Company Information
6.7.2 CSL Description and Business Overview
6.7.3 CSL Blood Coagulants Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CSL Blood Coagulants Product Portfolio
6.7.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Coagulants Industry Chain Analysis
7.2 Blood Coagulants Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Coagulants Production Mode & Process Analysis
7.4 Blood Coagulants Sales and Marketing
7.4.1 Blood Coagulants Sales Channels
7.4.2 Blood Coagulants Distributors
7.5 Blood Coagulants Customer Analysis
8 Blood Coagulants Market Dynamics
8.1 Blood Coagulants Industry Trends
8.2 Blood Coagulants Market Drivers
8.3 Blood Coagulants Market Challenges
8.4 Blood Coagulants Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Bayer
Novo Nordisk
Takeda
SOBI
Octapharma AG
CSL Limited
List of Tables
 Table 1. Global Blood Coagulants Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Blood Coagulants Market Value by Sale Channel (2024 VS 2031) & (US$ Million)
 Table 3. Global Blood Coagulants Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Blood Coagulants Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Blood Coagulants Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Blood Coagulants Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Blood Coagulants Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Blood Coagulants Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Blood Coagulants, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Blood Coagulants, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Blood Coagulants, Product Type & Application
 Table 12. Global Key Manufacturers of Blood Coagulants, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Blood Coagulants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Coagulants as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Blood Coagulants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Blood Coagulants Sales by Region (2020-2025) & (K Units)
 Table 18. Global Blood Coagulants Sales Market Share by Region (2020-2025)
 Table 19. Global Blood Coagulants Sales by Region (2026-2031) & (K Units)
 Table 20. Global Blood Coagulants Sales Market Share by Region (2026-2031)
 Table 21. Global Blood Coagulants Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Blood Coagulants Revenue Market Share by Region (2020-2025)
 Table 23. Global Blood Coagulants Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Blood Coagulants Revenue Market Share by Region (2026-2031)
 Table 25. North America Blood Coagulants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Blood Coagulants Sales by Country (2020-2025) & (K Units)
 Table 27. North America Blood Coagulants Sales by Country (2026-2031) & (K Units)
 Table 28. North America Blood Coagulants Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Blood Coagulants Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Blood Coagulants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Blood Coagulants Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Blood Coagulants Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Blood Coagulants Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Blood Coagulants Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Blood Coagulants Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Blood Coagulants Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Blood Coagulants Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Blood Coagulants Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Blood Coagulants Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Blood Coagulants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Blood Coagulants Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Blood Coagulants Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Blood Coagulants Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Blood Coagulants Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Blood Coagulants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Blood Coagulants Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Blood Coagulants Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Blood Coagulants Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Blood Coagulants Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Blood Coagulants Sales (K Units) by Type (2020-2025)
 Table 51. Global Blood Coagulants Sales (K Units) by Type (2026-2031)
 Table 52. Global Blood Coagulants Sales Market Share by Type (2020-2025)
 Table 53. Global Blood Coagulants Sales Market Share by Type (2026-2031)
 Table 54. Global Blood Coagulants Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Blood Coagulants Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Blood Coagulants Revenue Market Share by Type (2020-2025)
 Table 57. Global Blood Coagulants Revenue Market Share by Type (2026-2031)
 Table 58. Global Blood Coagulants Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Blood Coagulants Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Blood Coagulants Sales (K Units) by Sale Channel (2020-2025)
 Table 61. Global Blood Coagulants Sales (K Units) by Sale Channel (2026-2031)
 Table 62. Global Blood Coagulants Sales Market Share by Sale Channel (2020-2025)
 Table 63. Global Blood Coagulants Sales Market Share by Sale Channel (2026-2031)
 Table 64. Global Blood Coagulants Revenue (US$ Million) by Sale Channel (2020-2025)
 Table 65. Global Blood Coagulants Revenue (US$ Million) by Sale Channel (2026-2031)
 Table 66. Global Blood Coagulants Revenue Market Share by Sale Channel (2020-2025)
 Table 67. Global Blood Coagulants Revenue Market Share by Sale Channel (2026-2031)
 Table 68. Global Blood Coagulants Price (USD/Unit) by Sale Channel (2020-2025)
 Table 69. Global Blood Coagulants Price (USD/Unit) by Sale Channel (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Blood Coagulants Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Bayer Blood Coagulants Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. Novo Nordisk Company Information
 Table 81. Novo Nordisk Description and Business Overview
 Table 82. Novo Nordisk Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Novo Nordisk Blood Coagulants Product
 Table 84. Novo Nordisk Recent Developments/Updates
 Table 85. Takeda Company Information
 Table 86. Takeda Description and Business Overview
 Table 87. Takeda Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Takeda Blood Coagulants Product
 Table 89. Takeda Recent Developments/Updates
 Table 90. SOBI Company Information
 Table 91. SOBI Description and Business Overview
 Table 92. SOBI Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. SOBI Blood Coagulants Product
 Table 94. SOBI Recent Developments/Updates
 Table 95. Octapharma Company Information
 Table 96. Octapharma Description and Business Overview
 Table 97. Octapharma Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Octapharma Blood Coagulants Product
 Table 99. Octapharma Recent Developments/Updates
 Table 100. CSL Company Information
 Table 101. CSL Description and Business Overview
 Table 102. CSL Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. CSL Blood Coagulants Product
 Table 104. CSL Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Blood Coagulants Distributors List
 Table 108. Blood Coagulants Customers List
 Table 109. Blood Coagulants Market Trends
 Table 110. Blood Coagulants Market Drivers
 Table 111. Blood Coagulants Market Challenges
 Table 112. Blood Coagulants Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Blood Coagulants
 Figure 2. Global Blood Coagulants Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Blood Coagulants Market Share by Type: 2024 & 2031
 Figure 4. Recombinant Coagulation Factor Product Picture
 Figure 5. Plasma Coagulation Factor Product Picture
 Figure 6. Global Blood Coagulants Market Value by Sale Channel (2020-2031) & (US$ Million)
 Figure 7. Global Blood Coagulants Market Share by Sale Channel: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Other
 Figure 11. Global Blood Coagulants Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Blood Coagulants Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Blood Coagulants Sales (2020-2031) & (K Units)
 Figure 14. Global Blood Coagulants Average Price (USD/Unit) & (2020-2031)
 Figure 15. Blood Coagulants Report Years Considered
 Figure 16. Blood Coagulants Sales Share by Manufacturers in 2024
 Figure 17. Global Blood Coagulants Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Blood Coagulants Players: Market Share by Revenue in Blood Coagulants in 2024
 Figure 19. Blood Coagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Blood Coagulants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Blood Coagulants Sales Market Share by Country (2020-2031)
 Figure 22. North America Blood Coagulants Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Blood Coagulants Sales Market Share by Country (2020-2031)
 Figure 26. Europe Blood Coagulants Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Blood Coagulants Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Blood Coagulants Revenue Market Share by Region (2020-2031)
 Figure 34. China Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Blood Coagulants Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Blood Coagulants Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Blood Coagulants Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Blood Coagulants Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Blood Coagulants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Blood Coagulants by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Blood Coagulants by Type (2020-2031)
 Figure 56. Global Blood Coagulants Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Blood Coagulants by Sale Channel (2020-2031)
 Figure 58. Global Revenue Market Share of Blood Coagulants by Sale Channel (2020-2031)
 Figure 59. Global Blood Coagulants Price (USD/Unit) by Sale Channel (2020-2031)
 Figure 60. Blood Coagulants Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Blood Coagulation Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostasis Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostat Powder and Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostat Powder and Tissue Sealing Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Powder Absorbable Hemostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Surgical Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Clotting Factor Market Research Report 2025
Global Blood Transfusion Market Research Report 2025
Blood Transfusion Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma Processing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood Banking and Blood Products Market Research Report 2024
Global Anticoagulant Drugs Market Insights Forecast to 2030
Hemostat Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stationary Hemostasis Analyzers Market Research Report 2024
Blood Coagulators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostatic Product Market Research Report 2025
Global Hemostasis Diagnostic Device Market Research Report 2025
Hemostatic and Tissue Sealing Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions